Y.S.P. Industries to market TaiGen’s new drug in Malaysia and Singapore
The contract was signed through TaiGen’s subsidiary company TaiGen Biotechnology. Considering the competitiveness of the pharmaceutical market as well as concerns about proprietary information, the companies did not